Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 511

recruiting
3 972
countries
28
conditions
2 123

10 535 trials match your criteria

Drug level

Not recruiting

Effect of multiple doses of BI 1358894 on the pharmacokinetics of ethinylestradiol and drospirenone in healthy women

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:BI 1358894

HIV infection

Not recruiting

Safety, Tolerability and Antiretroviral Activity of a Single Oral Dose of MK-8527 in ART‑Naïve Adults with HIV‑1

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:MK-8527

Iron overload

Not recruiting

Safety and Tolerability of REGN7999 in Healthy Adult Participants

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:REGN7999

Pericarditis

Not recruiting

Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Nipocalimab
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Hydrochlorothiazide
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Cytisinicline
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Nicorandil

Psoriasis

Not recruiting

A study to examine how the body processes and removes DC-806 in healthy male volunteers

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:DC-806

Drug level

Not recruiting

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:BI 685509

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Camizestrant

Neoplasm malignant

Not recruiting

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:NG-350A
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.